Bolt Biotherapeutics Inc BOLT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
1.10UNCH (UNCH)
Volume
37,267
52 week range
0.84 - 2.03
Loading...
  • Open1.12
  • Day High1.12
  • Day Low1.04
  • Prev Close1.10
  • 52 Week High2.03
  • 52 Week High Date05/23/23
  • 52 Week Low0.84
  • 52 Week Low Date12/01/23

Key Stats

  • Market Cap41.941M
  • Shares Out38.13M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-1.79

KEY STATS

  • Open1.12
  • Day High1.12
  • Day Low1.04
  • Prev Close1.10
  • 52 Week High2.03
  • 52 Week High Date05/23/23
  • 52 Week Low0.84
  • 52 Week Low Date12/01/23
  • Market Cap41.941M
  • Shares Out38.13M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-1.79

RATIOS/PROFITABILITY

  • EPS (TTM)-1.83
  • P/E (TTM)-0.60
  • Fwd P/E (NTM)-0.60
  • EBITDA (TTM)-74.342M
  • ROE (TTM)-48.69%
  • Revenue (TTM)7.876M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-878.58%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bolt Biotherapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The Company's pipeline candidates are built on its expertise in myeloid biology and cancer drug development. Its pipeline includes trastuzumab imbotolimod (formerly BDC-1001), a human epidermal growth factor receptor 2 - targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple...
Randall Schatzman Ph.D.
Chief Executive Officer, Director
William Quinn
Chief Financial Officer
Address
900 Chesapeake Drive
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
MRKR
Marker Therapeutics Inc
4.11-0.09-2.14%
ICCC
ImmuCell Corp
5.03+0.03+0.60%
PTN
Palatin Technologies Inc
2.11+0.06+2.93%
IKNA
Ikena Oncology Inc
1.32UNCHUNCH
KZR
Kezar Life Sciences Inc
0.8574+0.0027+0.3159%